Extract/ form | Part used | Compound | Dose | Model | In vitro | In vivo | Induction | Activity | Target | Reference |
---|---|---|---|---|---|---|---|---|---|---|
Powder | Peel and seed | - | 100 and 200 mg/kg | Rats | - | ✓ | STZ | Antidiabetic and antihyperlipidemic | β-cells, insulin secretion and release, insulin sensitivity | (Sabitha et al., 2011) |
Methanol | Seed | Isoquercetin and quercetin-3-O-beta-glucopyranosyl-(1→6)-glucoside | 1 mg/mL | - | ✓ | - | - | Antidiabetic | α-Glucosidase, selectively inhibited rat intestinal maltase and sucrase | (Thanakosai & Phuwapraisirisan, 2013) |
Aqueous extract | Pods | Rhamnogalacturonan | 200 mg/kg b.w/day | Rats | - | ✓ | STZ | Hypoglycemic effect | - | (Wu et al., 2020) |
Powder | Dried okra | Flavonoids, phenolic acids | 200 mg/kg/day | Rats | - | ✓ | STZ | Antihyperglycemic effect | Improve glucose homeostasis, β-cells impairment | (Majd et al., 2018) |
Ethanol extract, n-hexane, ethyl acetate, and water | Fruit | Quercetin, triterpenoids | 200, 107, 6, and 86 mg/kg b.w | Rats | - | ✓ | STZ-NA | Antidiabetic Activity | Pancreatic beta cells, inhibition of aldose reductase enzyme | (Herowati et al., 2020) |
Aqueous and methanolic | Seed | Phenols, terpenoids | 200 mg/kg, p.o. | Mice | - | ✓ | Scopolamine | Nootropic activities | - | (Doreddula et al., 2014) |
Aqueous | Fruits | Polysaccharides | 600 mg/kg | Mice | - | ✓ | Aβ1–42 | Cognitive function, antidiabetic and antiobesity activity in AD mice | - | (Yan et al., 2020) |
60% aqueous ethanol | Fruits | Flavonoids | 100 and 300 mg/kg | Kunming mice | - | ✓ | Aβ1–42 | Cognitive impairment, AD neuroinflammation. | BDNF | (Yan et al., 2021) |
Ethanol | Pod | Catechin epicatechin procyanidin B1 and B2 quercetin and rutin | 60 mg/kg/mL by p.o. | Mice | - | ✓ | Dexamethasone | Neuroprotective, memory function | - | (Tongjaroenbuangam et al., 2011) |
Powder | Root | Quercetin | 1600 mg/kg b.w | Rats | - | ✓ | Repeated noise | Cognitive function | - | (Samad et al., 2020) |